CVE:ADK DIAGNOS (ADK) Stock Price, News & Analysis → Catalyst Could Trigger 10,000% Crypto Gains (From Crypto 101 Media) (Ad) Free ADK Stock Alerts C$0.30 -0.02 (-4.76%) (As of 01:50 PM ET) Add Compare Share Share Today's RangeC$0.30▼C$0.3250-Day RangeC$0.28▼C$0.3352-Week RangeC$0.23▼C$0.59Volume51,680 shsAverage Volume85,720 shsMarket CapitalizationC$23.33 millionP/E RatioN/ADividend Yield0.29%Price TargetC$1.50 Stock AnalysisStock AnalysisAnalyst ForecastsChartEarningsHeadlinesInsider TradesStock AnalysisAnalyst ForecastsChartEarningsHeadlinesInsider Trades Get DIAGNOS alerts: Email Address Ad Insiders Exposed$5k to $1.3m in just 3 tradesIt doesn’t happen often, but occasionally, something completely unique comes across my radar. In this case, I’m talking about legal “Insider Trading”. Traders who have consistently signaled 453% … 610% .. and even 1036%... gains. And until now they have been doing it completely under the radar. In an upcoming interview I am revealing the strategy behind this gold-mine and how you can piggy back their every trade.Register for the imminent briefing here. About DIAGNOS Stock (CVE:ADK)DIAGNOS Inc. provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy; and allows eye care specialist to visualize both normal retinal landmarks and pathological changes. It also provides various consulting services in the fields of data analysis and artificial intelligence. DIAGNOS Inc. was founded in 1998 and is headquartered in Brossard, Canada.Read More ADK Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart ADK Stock News HeadlinesFebruary 23, 2024 | ca.finance.yahoo.comGot $1,000? 2 Stocks to Buy Now While They’re on SaleFebruary 21, 2024 | finance.yahoo.comDIAGNOS recognized as a Top TSX Venture Exchange CompanyJune 18, 2024 | Insiders Exposed (Ad)917 Trades… Zero Losses?If you want to learn how A Group of traders Made 917 Trades Without A Single Loss! And How You Could Have Consistently Beat the Market by following them...February 9, 2024 | theglobeandmail.comClosing Bell: Diagnos Inc flat on Thursday (ADK)January 16, 2024 | msn.comDiagnos appoints Yves-Stéphane Couture as chief operating officerJanuary 16, 2024 | finance.yahoo.comDIAGNOS Appoints New Chief Operating OfficerDecember 8, 2023 | finance.yahoo.comCanadian Investment Regulatory Organization Trading Halt - ADKNovember 18, 2023 | finance.yahoo.comDIAGNOS Inc. (ADK.V)June 18, 2024 | Insiders Exposed (Ad)917 Trades… Zero Losses?If you want to learn how A Group of traders Made 917 Trades Without A Single Loss! And How You Could Have Consistently Beat the Market by following them...November 14, 2023 | msn.comThe last government shutdown deadline ousted the House speaker. This week's showdown could be easierNovember 4, 2023 | theglobeandmail.comClosing Bell: Diagnos Inc flat on Friday (ADK)October 24, 2023 | investing.comDiagnos Laboratorium Utama PT Tbk (DGNS)October 7, 2023 | stockhouse.comDIAGNOS AI Retina Analysis is being deployed across Canada's Largest Specialist Care Provider in Diabetes & EndocrinologyOctober 5, 2023 | finance.yahoo.comDIAGNOS AI Retina Analysis is being deployed across Canada’s Largest Specialist Care Provider in Diabetes & EndocrinologySeptember 8, 2023 | baystreet.caDiagnos, Appulse, Bedford at 52-Week HighsJuly 15, 2023 | theglobeandmail.comClosing Bell: Diagnos Inc down on Friday (ADK)July 6, 2023 | markets.businessinsider.comEchelon Wealth Partners Believes Diagnos (ADK) Won’t Stop HereMay 17, 2023 | finance.yahoo.comDIAGNOS and IRIS, The Visual Group strengthen partnership with the launch of “IRIS-ai powered by DIAGNOS”May 15, 2023 | baystreet.caTMX, Arrow, CPKC at 52-Week Highs on NewsMay 11, 2023 | usatoday.comMichael J. Fox: Do you have Parkinson's? New test is 'breakthrough' in diagnosing disease.May 4, 2023 | theglobeandmail.comClosing Bell: Diagnos Inc up on Wednesday (ADK)May 2, 2023 | theglobeandmail.comClosing Bell: Diagnos Inc up on Monday (ADK)April 28, 2023 | theglobeandmail.comClosing Bell: Diagnos Inc up on Thursday (ADK)April 19, 2023 | theglobeandmail.comClosing Bell: Diagnos Inc up on Tuesday (ADK)February 28, 2023 | finance.yahoo.comDIAGNOS and ÉTS Unveil a Method to Adapt Deep Learning Algorithms According to the Diversity of ContextsDecember 15, 2022 | finance.yahoo.comDIAGNOS Provides Additional Information to the Closing of Private PlacementNovember 6, 2022 | reuters.comADK.V - Diagnos Inc | Stock Price & Latest News | ReutersSee More Headlines Receive ADK Stock News and Ratings via Email Sign-up to receive the latest news and ratings for DIAGNOS and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today6/18/2024Next Earnings (Estimated)7/11/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeCVE SectorMedical Industry Health Information Services Sub-IndustryN/A Current SymbolCVE:ADK CUSIPN/A CIKN/A Webwww.diagnos.ca Phone+1-450-6788882FaxN/AEmployeesN/AYear FoundedN/APrice Target and Rating Average Stock Price TargetC$1.50 High Stock Price TargetC$1.50 Low Stock Price TargetC$1.50 Potential Upside/Downside+376.2%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)C($0.04) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeC$-3,040,000.00 Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on Assets-150.84% Debt Debt-to-Equity Ratio245.28 Current Ratio0.70 Quick Ratio0.68 Sales & Book Value Annual SalesC$577,486.00 Price / Sales42.42 Cash FlowC$0.01 per share Price / Cash Flow60.00 Book ValueC($0.04) per share Price / Book-7.88Miscellaneous Outstanding Shares77,770,000Free FloatN/AMarket CapC$24.50 million OptionableNot Optionable Beta-0.43 5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report Key ExecutivesMr. Andre LarenteCEO, President & Executive ChairmanMr. Marc-André MassueVP of Finance, CFO & SecretaryMr. Yves-Stéphane CoutureChief Operating OfficerMr. Martin BelandDirector of MarketingKey CompetitorsReliq Health TechnologiesCVE:RHTCloudMD Software & ServicesCVE:DOCCardioComm SolutionsCVE:EKGZoomMedCVE:ZMDCann AmericanCNSX:CNNAView All CompetitorsInsidersTristram CoffinSold 800,000 sharesTotal: C$240,000.00 ($0.30/share)View All Insider Transactions ADK Stock Analysis - Frequently Asked Questions Should I buy or sell DIAGNOS stock right now? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for DIAGNOS in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" ADK shares. View ADK analyst ratings or view top-rated stocks. What is DIAGNOS's stock price target for 2024? 1 equities research analysts have issued twelve-month price objectives for DIAGNOS's stock. Their ADK share price targets range from C$1.50 to C$1.50. On average, they expect the company's stock price to reach C$1.50 in the next twelve months. This suggests a possible upside of 383.9% from the stock's current price. View analysts price targets for ADK or view top-rated stocks among Wall Street analysts. How have ADK shares performed in 2024? DIAGNOS's stock was trading at C$0.41 at the start of the year. Since then, ADK stock has decreased by 23.5% and is now trading at C$0.31. View the best growth stocks for 2024 here. When is DIAGNOS's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, July 11th 2024. View our ADK earnings forecast. What other stocks do shareholders of DIAGNOS own? Based on aggregate information from My MarketBeat watchlists, some companies that other DIAGNOS investors own include Marijuana Company of America (MCOA), Maxar Technologies (MAXR) and Main Street Capital (MAIN). How do I buy shares of DIAGNOS? Shares of ADK stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (CVE:ADK) was last updated on 6/18/2024 by MarketBeat.com Staff From Our PartnersAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentia...Priority Gold | SponsoredBigger Than NVIDIA?With NVIDIA flying high, everyone is looking for the next breakout stock. But right now... There's only ...Behind the Markets | SponsoredBeta testers blew this thing upThis AI trading tool is probably unlike anything you've ever seen before… It scans the entire market and fi...Prosper Trading Academy | SponsoredCatalyst Could Trigger 10,000% Crypto GainsAre you monitoring 13,217 cryptocurrencies everyday? If not, you could miss the ONE that can make you wealt...Crypto 101 Media | SponsoredBiden Nomination CANCELED?And I believe when they do take the oath of office, their fingers will be crossed… and America will descend in...The Freeport Society | SponsoredThe ONE AI Stock to own now. (It’s not Nvidia.)Don’t panic — you haven’t missed the boat on AI. In fact, it has barely launched. Sure, the early stages...Weiss Ratings | SponsoredElon Musk: THIS will be bigger than TeslaIf you missed out on crypto, this could be your second chance. The AI “wealth window” is opening now, but you ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DIAGNOS Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share DIAGNOS With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.